19th Nov 2013 13:36
LONDON (Alliance News) - Skyepharma PLC said Tuesday that its partner Kyorin Pharmaceutical Co, Ltd. had launched its asthma treatment flutiform in Japan.
Flutiform was first developed by Skyepharma in 2004, and Kyorin was appointed as Skyepharma's development partner and distributor for the product in Japan in 2008.
"The launch of flutiform by Kyorin brings a new inhaled treatment option to people suffering from asthma in Japan," said Chief Executive Officer Peter Grant in a statement. "Kyorin has already established a strong and highly successful position in the Japanese respiratory market and has built excellent relationships with key opinion leaders and clinicians in the field."
Shares in the pharmaceutical company were trading down 0.70 pence at 113.30 pence Tuesday afternoon.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
SKP.L